Protective effect of L-carnitine on hyperammonemia

Area of Science:

• Biochemistry
• Toxicology
• Pharmacology

Background:

• Hyperammonemia, resulting from urea cycle disorders, liver issues, or drug toxicity, causes severe encephalopathies.
• Ammonia toxicity poses a significant life-threatening risk.

Purpose of the Study:

• To investigate the efficacy of L-Carnitine in preventing and treating ammonia toxicity.
• To determine the dose-dependent protective effects of L-Carnitine against hyperammonemia.

Main Methods:

• Mice were administered L-Carnitine intraperitoneally before lethal doses of ammonium acetate.
• Survival rates and onset of ammonia-induced convulsions were monitored.
• Sustained hyperammonemia was induced using urease injections.

Main Results:

• L-Carnitine completely prevented ammonia toxicity in mice at higher doses (8-16 mmol/kg).
• Survival rates increased with L-Carnitine dosage, with 100% survival at 16 mmol/kg.
• L-Carnitine significantly reduced blood ammonia levels and abolished or delayed convulsions.

Conclusions:

• L-Carnitine demonstrates potent protective effects against acute and sustained hyperammonemia in a murine model.
• The findings suggest L-Carnitine as a potential therapeutic agent for managing ammonia toxicity.
• Further research is needed to elucidate the precise mechanism of L-Carnitine's protective action.